The use of inhaled steroids reduces the risk of developing lung cancer in people with chronic obstructive pulmonary disease (COPD), a study suggests. The study, titled “Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study,” was published…
News
Add-on treatment with asthma medication Fasenra (benralizumab) failed to reduce annual exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), according to final results of two Phase 3 trials. Findings were reported in the study, “Benralizumab for the Prevention of COPD Exacerbations,”…
Piedmont Atlanta announced that it is the first hospital in the state of Georgia to offer treatment for emphysema with the Zephyr Valve System, a minimally invasive therapy for better lung function and exercise tolerance without the need for surgery. Patients with emphysema, a severe form of chronic…
A post-hoc analysis showed that nebulized ensifentrine (RPL544) is highly effective for relieving respiratory symptoms in chronic obstructive pulmonary disease (COPD) patients with either reversible or non-reversible airway obstruction, although the effect is greater for those with reversible disease, according to Verona Pharma, ensifentrine’s developer. Over a treatment…
Verona Pharma started a Phase 2b dose-ranging study testing the safety and efficacy of nebulized ensifentrine (RPL554) as an add-on to a standard long-acting bronchodilator in people with moderate to severe chronic obstructive pulmonary disease (COPD), the company announced. The inhaled dual inhibitor ensifentrine targets the enzymes phosphodiesterase…
Azithromycin treatment initiated during hospitalization for an acute exacerbation of chronic obstructive pulmonary disease (COPD), followed by three months of a low-maintenance dose, seems to reduce treatment failure. The results were reported in “Azithromycin during Acute COPD Exacerbations Requiring Hospitalization (BACE): a Multicentre, Randomized, Double-blind, Placebo-controlled Trial,” published in…
Video telehealth rehabilitation reduced the rates that patients with chronic obstructive pulmonary disease (COPD) had to be readmitted within 30 days after they were hospitalized for a pulmonary exacerbation, according to a study. The findings were published in the American Journal of Respiratory and Critical Care Medicine in a…
With the prevalence of type 2 diabetes and chronic obstructive pulmonary disease (COPD) rising, a team of researchers is discussing the latest research linking both diseases, and the recommended therapeutic approaches for patients with coexisting COPD and diabetes. The study “COPD and Type 2 Diabetes,” published in the journal…
Chronic obstructive pulmonary disease (COPD) patients who are exposed frequently to biomass smoke emitted by burning wood and coal have a similar risk of exacerbation — acute pulmonary symptoms worsening — as patients who smoke tobacco, a study suggests. As a result of this finding, biomass smoke should be…
Canadian wellness app Carrot Rewards has announced a new campaign in collaboration with The Lung Association — Ontario and Boehringer Ingelheim (Canada) to reach chronic obstructive pulmonary disease (COPD) patients and educate users about the disease. Carrot Rewards is an artificial intelligence-driven wellness app and brand engagement…
Recent Posts
- A diagnosis is a map that shows our way through an unknown land
- US study names COPD therapy Anoro Elipta top choice for new patients
- Applying wise old sayings to a different body with COPD
- I maintain my morning rituals to keep COPD from shrinking my world
- Living with COPD isn’t a test that I have to pass